Global BPGen Consortium United States of America (USA)
Research
Date range: 1 August 2022 - 31 July 2023
Research collaboration: Global BPGen Consortium is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
Global BPGen Consortium is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Aberdeen Royal Infirmary, NHS Grampian
- Azienda Sanitaria di Firenze (ASF)
- Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP)
- Broad Institute of MIT and Harvard
- CEA Centre National de Génotypage (CNG)
- Cambridge-Genetics of Energy Metabolism (GEM) Consortium
- Cordelier Research Center (CRC)
- Framingham Heart Study (FHS)
- GlaxoSmithKline USA
- Harvard University
- Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU)
- Hospital del Mar Medical Research Institute (IMIM)
- IRCCS Istituto Nazionale Ricovero e Cura per Anziani (INRCA)
- Imperial College London (ICL)
- Institute for Molecular Medicine Finland (FIMM)
- Institute for Scientific Interchange (ISI)
- Institute of Genetic and Biomedical Research (IRGB), CNR
- Institute of Neuroscience (IN), CNR
- JDRF/Wellcome Trust Diabetes and Inflammation Laboratory (JDRF/Wellcome Trust DIL)
- Karolinska Institute (KI)
- King's College London (KCL)
- Kuopio University Hospital (KUH)
- Leibniz Institute for Arteriosclerosis Research (LIFA)
- Ludwig Maximilians University of Munich (LMU)
- Lund University (LU)
- MRC Epidemiology Unit, University of Cambridge
- MRC Mitochondrial Biology Unit (MBU), University of Cambridge
- Mario Negri Sud Foundation (FMNS)
- Massachusetts General Hospital (MGH)
- MedStar Health
- NIH National Human Genome Research Institute (NHGRI)
- NIH National Institute on Aging (NIA)
- NIHR Oxford Biomedical Research Centre (OxBRC)
- National Institute for Health and Welfare (THL)
- Nutritional Epidemiology Research Unit (UREN)
- Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)
- Oxford Wellcome Trust Centre for Human Genetics
- Piedmont Reference Center for Epidemiology and Cancer Prevention (CPO Piemonte)
- Pontifical Catholic University of Chile (PUC)
- South Ostrobothnia Health Care District (SO HCD)
- St George's, University of London (SGUL)
- Swiss Institute of Bioinformatics (SIB)
- TUM-HMGU Institute of Human Genetics (IHG)
- Technical University of Munich (TUM)
- The Hospital for Sick Children (SickKids), U of T
- The University of North Carolina at Chapel Hill (UNC)
- The University of Texas MD Anderson Cancer Center
- UCLA Health
- University Hospital of Lausanne (CHUV), UNIL
- University Medical Center Groningen (UMCG), RUG
- University Medical Center Utrecht (UMC Utrecht)
- University of Bristol (UoB)
- University of Cambridge
- University of Glasgow
- University of Greifswald
- University of Helsinki
- University of Lausanne (UNIL)
- University of Leicester
- University of Michigan (U-M)
- University of Naples Federico II (UNINA)
- University of Oulu
- University of Oxford
- University of Southern California (USC)
- University of Tartu (UT)
- University of Turin (UNITO)
- University of Washington (UW)
- Uppsala University (UU)
- VU University Medical Center (VUmc)
- Wellcome Sanger Institute
- Wellcome Trust Case Control Consortium (WTCCC)
- William Harvey Research Institute (WHRI), QMUL